Table 2.
IL-2 | IFN-γ | IL-4 | ||
---|---|---|---|---|
Patients with HT plus NEAD | No. of patients | Median % of positive cells (IQ1–IQ3) | ||
Chronic atrophic gastritis (CAG) | 18 | 36·7 | 33·0‡ | 15·9 |
(32·8–45·3) | (25·53–42·3) | (7·8–21·8) | ||
Coeliac disease | 7 | 40·1 | 29·9 | 22·6 |
(28·7–42) | (22·3–40·3) | (15·3–39·8) | ||
Vitiligo | 6 | 23·7 | 13·5‡ | 20·6 |
(22·7–34·8) | (12·2–16·9) | (15·6–21·3) | ||
Sjögren's syndrome | 4 | 38·9 | 26 | 14·9 |
(30·8–45) | (11·2–22·2) | (18–33·4) | ||
P† | 0·3678 | 0·0051 | 0·3438 |
Analysis of variance (anova) test was used as statistical analysis.
Kruskal–Wallis post-test: CAG versus vitiligo P < 0·01.
IQ, interquartile.